• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[α-突触核蛋白病患者血液和脑脊液中的α-突触核蛋白]

[Alpha-Synuclein in blood and cerebrospinal fluid of patients with alpha-synucleinopathy].

作者信息

Ono Kenjiro, Yamada Masahito

出版信息

Rinsho Byori. 2014 Mar;62(3):241-5.

PMID:24800499
Abstract

Alpha-Synuclein protein(alphaS) aggregates from a monomer to assemblies such as oligomers, protofibrils, and mature fibrils. The early intermediate aggregate, that is, the oligomer, has been reported to be the most toxic species. We recently reported that melatonin inhibits alphaS aggregation, including protofibril and oligomer formations. While the alphaS concentration in cerebrospinal fluid was reported to significantly decrease in patients with Parkinson's disease (PD) and dementia with Lewy bodies, there have been reports that the alphaS oligomer concentration was elevated in the cerebrospinal fluid of PD patients. Moreover, it was reported that the alphaS oligomer concentration was also elevated in the blood of PD patients. Further studies may establish alphaS in cerebrospinal fluid and blood as a biomarker of alpha-synucleinopathies, including PD.

摘要

α-突触核蛋白(αS)从单体聚集成诸如寡聚体、原纤维和成熟纤维等聚集体。据报道,早期中间聚集体,即寡聚体,是毒性最强的物质。我们最近报道褪黑素可抑制αS聚集,包括原纤维和寡聚体的形成。虽然据报道帕金森病(PD)和路易体痴呆患者脑脊液中的αS浓度显著降低,但也有报道称PD患者脑脊液中的αS寡聚体浓度升高。此外,据报道PD患者血液中的αS寡聚体浓度也升高。进一步的研究可能会将脑脊液和血液中的αS确立为包括PD在内的α-突触核蛋白病的生物标志物。

相似文献

1
[Alpha-Synuclein in blood and cerebrospinal fluid of patients with alpha-synucleinopathy].[α-突触核蛋白病患者血液和脑脊液中的α-突触核蛋白]
Rinsho Byori. 2014 Mar;62(3):241-5.
2
[Α-synuclein as a biomarker for early diagnosis of Parkinsonism].[α-突触核蛋白作为帕金森综合征早期诊断的生物标志物]
Rinsho Shinkeigaku. 2013;53(11):983-5. doi: 10.5692/clinicalneurol.53.983.
3
[α-Synuclein as Diagnostic Biomarker].[α-突触核蛋白作为诊断生物标志物]
Brain Nerve. 2020 Feb;72(2):137-141. doi: 10.11477/mf.1416201493.
4
α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study.帕金森病患者脑脊液中α-突触核蛋白和tau 浓度:一项队列研究。
Lancet Neurol. 2011 Mar;10(3):230-40. doi: 10.1016/S1474-4422(11)70014-X.
5
Induction of α-synuclein aggregate formation by CSF exosomes from patients with Parkinson's disease and dementia with Lewy bodies.帕金森病和路易体痴呆患者脑脊液来源外泌体诱导α-突触核蛋白聚集体形成
Brain. 2016 Feb;139(Pt 2):481-94. doi: 10.1093/brain/awv346. Epub 2015 Dec 8.
6
The Oligomer Hypothesis in α-Synucleinopathy.α-突触核蛋白病寡聚物假说。
Neurochem Res. 2017 Dec;42(12):3362-3371. doi: 10.1007/s11064-017-2382-x. Epub 2017 Aug 21.
7
In vivo markers of Parkinson's disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody.帕金森病和路易体痴呆的体内标志物:5G4 α-突触核蛋白抗体的当前价值
Acta Neuropathol. 2014 Dec;128(6):893-5. doi: 10.1007/s00401-014-1364-1. Epub 2014 Nov 7.
8
Investigating alpha-synuclein co-pathology in Alzheimer's disease by means of cerebrospinal fluid alpha-synuclein seed amplification assay.通过脑脊液 alpha-突触核蛋白种子扩增检测法研究阿尔茨海默病中的 alpha-突触核蛋白共病理。
Alzheimers Dement. 2024 Apr;20(4):2444-2452. doi: 10.1002/alz.13658. Epub 2024 Feb 7.
9
Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.检测人血浆中α-突触核蛋白的寡聚体形式作为帕金森病的潜在生物标志物。
FASEB J. 2006 Mar;20(3):419-25. doi: 10.1096/fj.03-1449com.
10
Cerebrospinal fluid of Alzheimer's disease and dementia with Lewy bodies patients enhances alpha-synuclein fibril formation in vitro.阿尔茨海默病和路易体痴呆患者的脑脊液在体外可增强α-突触核蛋白原纤维的形成。
Exp Neurol. 2007 Feb;203(2):579-83. doi: 10.1016/j.expneurol.2006.08.012. Epub 2006 Oct 2.

引用本文的文献

1
Cell Ratio Differences in Peripheral Blood between Early- and Late-Onset Parkinson's Disease: A Case-Control Study.外周血中早发性和晚发性帕金森病的细胞比例差异:一项病例对照研究。
Biomed Res Int. 2019 Nov 7;2019:2072635. doi: 10.1155/2019/2072635. eCollection 2019.
2
Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases.外周生物标志物在阿尔茨海默病和帕金森病的早期检测中的应用。
Mol Neurobiol. 2019 Mar;56(3):2256-2277. doi: 10.1007/s12035-018-1151-4. Epub 2018 Jul 14.